Top Markets
#1 Nesa Nesa +337.53%
#2 EXOD EXOD +22.78%
#3 MetaDAO MetaDAO +17.01%
#4 Status Status +12.64%
#5 Wrapped NXM Wrapped NXM +7.23%
#6 Kinesis Silver Kinesis Silver +6.60%
#7 Venom Venom +5.81%
#8 Tornado Cash Tornado Cash +4.89%
#9 HOME HOME +4.80%
#10 Ontology Gas Ontology Gas +3.99%
Coin of the day
Nesa Nesa
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG
Rang in aandelen #19830
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Aandeelprijs
$9.61
Laatst gesynchroniseerd: 2026-08-25
Marktkapitalisatie
$149.33M
Verandering (1 dag)
-1.39%
Verandering (1 jaar)
21.24%
Land
US
Handel Alpha Cognition Inc (ACOG)

Categorie

Healthcare
P/S-ratio voor Alpha Cognition Inc (ACOG)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Alpha Cognition Inc is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Alpha Cognition Inc van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH